TY - JOUR
T1 - Mechanical thrombectomy for the treatment of primary and secondary anterior cerebral artery occlusions
T2 - insights from STAR
AU - Dabhi, Nisha
AU - Kumar, Jeyan Sathia
AU - Ironside, Natasha
AU - Kellogg, Ryan T.
AU - Sowlat, Mohammad Mahdi
AU - Uchida, Kazutaka
AU - Maier, Ilko
AU - Kasab, Sami Al
AU - Jabbour, Pascal
AU - Kim, Joon Tae
AU - Wolfe, Stacey Q.
AU - Rai, Ansaar
AU - Starke, Robert M.
AU - Psychogios, Marios Nikos
AU - Samaniego, Edgar A.
AU - Arthur, Adam S.
AU - Yoshimura, Shinichi
AU - Cuellar, Hugo
AU - Howard, Brian M.
AU - Alawieh, Ali
AU - Romano, Daniele G.
AU - Tanweer, Omar
AU - Mascitelli, Justin
AU - Fragata, Isabel
AU - Polifka, Adam J.
AU - Osbun, Joshua W.
AU - Crosa, Roberto Javier
AU - Matouk, Charles
AU - Levitt, Michael R.
AU - Brinjikji, Waleed
AU - Moss, Mark
AU - Dumont, Travis M.
AU - Williamson, Richard
AU - Navia, Pedro
AU - Kan, Peter
AU - De Leacy, Reade
AU - Chowdhry, Shakeel A.
AU - Ezzeldin, Mohamad
AU - Spiotta, Alejandro M.
AU - Park, Min S.
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2024.
PY - 2024/12/1
Y1 - 2024/12/1
N2 - Background The safety and efficacy of mechanical thrombectomy (MT) for the treatment of acute anterior cerebral artery (ACA) occlusions have not clearly been delineated. Outcomes may be impacted based on whether the occlusion is isolated to the ACA (primary ACA occlusion) or occurs in conjunction with other cerebral arteries (secondary). Methods We performed a retrospective review of the multicenter Stroke Thrombectomy and Aneurysm (STAR) database. All patients with MT-treated primary or secondary ACA occlusions were included. Baseline characteristics, procedural outcomes, complications, and clinical outcomes were collected. Primary and secondary ACA occlusions were compared using the Mann–Whitney U test and Kruskal–Willis test for continuous variables and the χ2 test for categorical variables. Results The study cohort comprised 238 patients with ACA occlusions (49.2% female, median (SD) age 65.6 (16.7) years). The overall rate of successful recanalization was 75%, 90-day good functional outcome was 23%, and 90-day mortality was 35%. There were 44 patients with a primary ACA occlusion and 194 patients with a secondary ACA occlusion. When adjusted for baseline variables, the rates of successful recanalization (68% vs 76%, P=0.27), 90-day good functional outcome (41% vs 19%, P=0.38), and mortality at 90 days (25% vs 38%, P=0.12) did not differ between primary and secondary ACA occlusion groups. Conclusion Clinical and procedural outcomes are similar between MT-treated primary and secondary ACA occlusions for select patients. Our findings demonstrate the need for established criteria to determine ideal patient and ACA stroke characteristics amenable to MT treatment.
AB - Background The safety and efficacy of mechanical thrombectomy (MT) for the treatment of acute anterior cerebral artery (ACA) occlusions have not clearly been delineated. Outcomes may be impacted based on whether the occlusion is isolated to the ACA (primary ACA occlusion) or occurs in conjunction with other cerebral arteries (secondary). Methods We performed a retrospective review of the multicenter Stroke Thrombectomy and Aneurysm (STAR) database. All patients with MT-treated primary or secondary ACA occlusions were included. Baseline characteristics, procedural outcomes, complications, and clinical outcomes were collected. Primary and secondary ACA occlusions were compared using the Mann–Whitney U test and Kruskal–Willis test for continuous variables and the χ2 test for categorical variables. Results The study cohort comprised 238 patients with ACA occlusions (49.2% female, median (SD) age 65.6 (16.7) years). The overall rate of successful recanalization was 75%, 90-day good functional outcome was 23%, and 90-day mortality was 35%. There were 44 patients with a primary ACA occlusion and 194 patients with a secondary ACA occlusion. When adjusted for baseline variables, the rates of successful recanalization (68% vs 76%, P=0.27), 90-day good functional outcome (41% vs 19%, P=0.38), and mortality at 90 days (25% vs 38%, P=0.12) did not differ between primary and secondary ACA occlusion groups. Conclusion Clinical and procedural outcomes are similar between MT-treated primary and secondary ACA occlusions for select patients. Our findings demonstrate the need for established criteria to determine ideal patient and ACA stroke characteristics amenable to MT treatment.
KW - stroke
KW - thrombectomy
UR - https://www.scopus.com/pages/publications/85178010765
U2 - 10.1136/jnis-2023-020997
DO - 10.1136/jnis-2023-020997
M3 - Article
C2 - 37968114
AN - SCOPUS:85178010765
SN - 1759-8478
VL - 16
SP - 1282
EP - 1287
JO - Journal of NeuroInterventional Surgery
JF - Journal of NeuroInterventional Surgery
IS - 12
ER -